- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Benioff Children's Hospital San Francisco, California, United States
- University of Miami Hospital & Clinics Miami, Florida, United States
Clinical trial condition
Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Explore clinical trials studying Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia trial results
NCT02614066
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- UC San Diego-Moores Cancer Center La Jolla, California, United States
- University of California Los Angeles (UCLA) Los Angeles, California, United States
- University of California Irvine Medical Center Orange, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
Active, Not Recruiting
Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
NCT06253663
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Chiba University Hospital Chiba, Japan
- Kyushu University Hospital Fukuoka, Japan
- Hokkaido University Hospital Hokkaido, Japan
- Kyoto University Hospital Kyoto, Japan